top of page
Ecosystem
Beta Site
Search Results
2 items found for "HMG-CoA reductase"
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
achieved complete remission, with or without hematologic count recovery (CR/CRi), and 32% exhibited a ≥50% reduction
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
ADC in patient-derived GBM xenografts in the brain of immunodeficient mice resulted in significant reduction
bottom of page